MET and hepatocellular carcinoma: Epigenetic upregulation of c-Met, the receptor for hepatocyte growth factor (HGF) is associated with HCC progression and metastasis in the TME, and it was shown that a significant decrease in DNA methylation during the hematogenous metastasis of HCC correlated with increased c-MET expression in circulating tumor cells [34].